Avermectins and milbemycins.
McKellar
Q A
QA
Department of Veterinary Pharmacology, University of Glasgow Veterinary School, UK.
Benchaoui
H A
HA
D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy; D003692:Delayed-Action Preparations; D007559:Ivermectin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D018942:Macrolides / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D013045:Species Specificity; D013329:Structure-Activity Relationship
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D003692:Delayed-Action Preparations; D018942:Macrolides; D007559:Ivermectin; C019264:avermectin; C027837:moxidectin